Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 5074-5087

  Al Jurf, Mahmoud ^a,c   Aranha, Francisco ^a,d   Annasetti, Claudio ^a   Apperley, Jane F ^a,e   Baynes, Roy ^a,f   Bensinger, William I ^a,g   Blaise, Didier ^a,h   Chaudhary, M Ashraf ^a,i   Clarke, Mike ^a,j   Cornelissen, Jan J ^a,k   Couban, Stephen ^a,l   Cutler, Corey ^a,m   Djulbegovic, Benjamin ^a,b   Gyger, Martin ^a,n   Gratwohl, Alois ^a,o   Heldal, Dag ^a,p   Hills, Robert K ^a,q   Van Der Holt, Bronno ^a,k   Hozo, Iztok ^a,r   Kuentz, Mathieu ^a,s   Kumar, Ambuj ^a   Lipton, Jeff ^a,t   Matcham, James ^a,f   Mohty, Mohamad ^a,h,u   Morton, James ^a,v   Panzarella, Tony ^a,t,w   Powles, Ray ^a,x   Richards, Sue M ^a,j   Sahovic, Entezam ^a,c   Schmitz, Norbert ^a,y   Simpson, David R ^a,z   Sirohi, Bhawna ^a,x   Soares, Heloisa P ^a   De Souza, Carmino A ^a,d   Vigorito, Afonso C ^a,d   Wheatley, Keith ^a,q   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f AMGEN INC   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l DALHOUSIE UNIVERSITY   (Canada)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ MCGILL UNIVERSITY   (Canada)

^o UNIVERSITY HOSPITAL BASEL   (Switzerland)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

^q UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^r INDIANA UNIVERSITY NORTHWEST   (United States)

^s HENRI MONDOR HOSPITAL   (France)

^t PRINCESS MARGARET HOSPITAL   (Canada)

^u Marseille and French Society of Transplantation (SFGM TC)   (France)

^v ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^w UNIVERSITY OF TORONTO   (Canada)

^x ROYAL MARSDEN HOSPITAL   (United Kingdom)

^y AK St Georg   (Germany)

^z NORTH SHORE HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; NEUTROPHIL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYSTEMATIC REVIEW; ALLOTRANSPLANTATION; BLOOD DISEASE; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK FACTOR; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 24644503670     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.020     Document Type: Article

References (39)

1. Gratwohl A, Baldomero H, Horisberger B, et al: Current trends in hematopoietic stem cell transplantation in Europe. Blood 100:2374-2386, 2002
2. Korbling M, Anderlini P, Hematology TA: Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter? Blood 98:2900-2908, 2001
3. Bensinger WI, Clift R, Martin P, et al: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794-2800, 1996
4. Bensinger WI, Deeg HJ: Blood or marrow? Lancet 355:1199-1200, 2000
5. Schmitz N, Barrett J: Optimizing Engraftment-Source and Dose of Stem Cells. Semin Hematology 39:3-14, 2002
6. Early Breast Cancer Trialists Collaborative Group: Introduction and methods section: Treatment of Early Breast Cancer. Worldwide Evidence 1985-1990. Oxford, UK, Oxford University Press, 1990
7. Stewart L, Clark M: For the Cochrane Collaboration Working Group on meta-analyses using individual patient data: Practical methodology of meta-analyses (overviewes) using updated individual patient data. Stat Med 14: 1057-1079, 1995
8. Clarke M, Oxman AD: Cochrane Reviewer's Handbook 4.1 [update July 20001, in Review Manager (Revman) [Computer Program]. version 4.1. Oxford, The Cochrane Collaboration, 1999
9. Clark L, Clark O, Wheatley K, et al: Allogeneic peripheral blood stem cells transplantation versus bone marrow transplantation for the therapy of hematological malignancies (Protocol for a Cochrane Review), in The Cochrane Library, Issue 4, 2003. Chichester, UK, John Wiley & Sons, Ltd, 2003
10. Clarke M, Stewart L: Obtaining individual patient data from randomised controlled trials, in Egger M, Smith GD, Altman DG (eds): Systematic Reviews in Health Care: Meta-Analysis in Context. London, UK, BMJ, 2001
11. The Myeloma Trialists' Collaborative Group: Intereferon as therapy for multiple myeloma: An individual patients data overview of 24 randomized trials and 4012 patients. Br J Haematol 113:1020-1034, 2001
12. Early Breast Cancer Trialists Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet 352:930-942, 1998
13. Morton J, Hutchins C, Durant S: Granulocyte-colony-stimulating (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 98:3186-3191, 2001
14. Vigorito AC, Azevedo WM, Marques JF, et al: A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 22:1145-1151, 1998
15. Vigorito AC, Comenalli Marques JF Jr, Penteado Aranha FJ, et al: A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: An update. Haematologica 86:665-666, 2001
16. Couban S, Simpson D, Barnett MJ, et al: A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100:1525-1531, 2002
17. Schmitz N, Beksac M, Hasenclever D, et al: Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standards-risk leukemia. Blood 100:761-767, 2002
18. Mahmoud H, Fahmy O, Kamel A, et al: Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 24:355-358, 1999
19. Blaise D, Kuentz M, Fortanier C, et al: Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 18:537-546, 2000
20. Cornelissen JJ, van der Holt B, Petersen EJ, et al: A randomized multicenter comparison of CD34+-selected progentor cells from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies. Exp Hematol 31:1-10, 2003
21. Heldal D, Tjonnfjord G, Brinch L, et al: A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 25:1129-1136, 2000
22. Powles R, Mehta J, Kulkarni S, et al: Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial. Lancet 355:1231-1237, 2000
23. Bensinger WI, Martin PJ, Storer B, et al: Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175-181, 2001
24. Moher D, Cook D, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet 354:1896-1900, 1999
25. Cutler C, Antin JH: Stem cell sources: Peripheral blood stem cells and bone marrow for allogeneic transplantation, in Soiffer RJ (ed): Stem Cell Transplantation for Hematologic Disorders. Humana Press, 2004, pp 337-356
26. Bensinger WI, Weaver CH, Appelbaum FR, et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658, 1995
27. Petiti DB: Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine (ed 2). New York, NY, Oxford Press, 2000
28. Wheatley K: SAB-a promising new treatment to improve remission rates in the elderly? Br J Haematol 118:432-433, 2002
29. Schulz KF, Chalmers I, Hayes R, et al: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408-412, 1995
30. Massi D, Franchi A, Pimpinelli N, et al: A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. Am J Clin Pathol 112:791-800, 1999
31. Vogelsang GB: How I treat chronic graft-versus-host disease? Blood 97:1196-1201, 2001
32. Gooley T, Leisenring W, Crowley J, et al: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706, 1999
33. Peggs K, Mackinnon S: Imatinib mesylate-the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048-1050, 2003
34. Lee S, Cook EF, Soiffer R, et al: Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 8:444-452, 2002
35. Sullivan K: Longterm followup and quality of life after hematopoeitic stem cell transplantation. J Rheumatol Suppl 48:46-52, 1997
36. Goerner M, Gooley T, Flowers ME, et al: Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 8:47-56, 2002
37. Miflin G, Russell NH, Franklin I, et al: An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation. Cytotherapy 2:423-428, 2000
38. Mohty M, Kuentz M, Michallet M, et al: Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: Long-term results of a randomized study. Blood 100:3128-3134, 2002
39. Collins R, McMahon S: Reliable assessment of the effects of treatment on mortality and major morbidity, I: Clinical trials. Lancet 357:373-380, 2001